Novocure Other Liab vs Non Currrent Assets Other Analysis
NVCR Stock | USD 21.50 0.65 2.93% |
Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Other Liab and its Non Currrent Assets Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.
Other Liab vs Non Currrent Assets Other
Other Liab vs Non Currrent Assets Other Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Other Liab account and Non Currrent Assets Other. At this time, the significance of the direction appears to have strong relationship.
The correlation between Novocure's Other Liab and Non Currrent Assets Other is 0.65. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Other Liab and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Novocure are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Other Liab i.e., Novocure's Other Liab and Non Currrent Assets Other go up and down completely randomly.
Correlation Coefficient | 0.65 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Other Liab
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.As of 06/08/2024, Selling General Administrative is likely to drop to about 87.6 M. In addition to that, Tax Provision is likely to drop to about 9.1 M
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 3.4M | 3.3M | 3.3M | 3.2M | Depreciation And Amortization | 10.3M | 10.6M | 11.0M | 7.8M |
Novocure fundamental ratios Correlations
Click cells to compare fundamentals
Novocure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Novocure fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 479.4M | 1.1B | 1.1B | 1.2B | 1.1B | 651.0M | |
Short Long Term Debt Total | 163.6M | 444.2M | 575.2M | 584.3M | 596.2M | 626.1M | |
Other Current Liab | (1K) | 35.7M | (17.8M) | (18.0M) | (16.2M) | (15.4M) | |
Total Current Liabilities | 86.3M | 113.6M | 142.6M | 158.8M | 179.1M | 188.1M | |
Total Stockholder Equity | 217.8M | 476.5M | 410.5M | 441.2M | 362.5M | 279.7M | |
Other Liab | 11.7M | 17.6M | 11.2M | 7.4M | 8.5M | 8.8M | |
Net Tangible Assets | 217.8M | 476.5M | 410.5M | 441.2M | 507.3M | 267.8M | |
Property Plant And Equipment Net | 34.6M | 41.6M | 53.9M | 69.0M | 97.7M | 102.6M | |
Net Debt | (13.8M) | 209.5M | 366.4M | 468.9M | 355.4M | 373.2M | |
Retained Earnings | (650.9M) | (631.1M) | (685.9M) | (778.5M) | (985.5M) | (936.2M) | |
Accounts Payable | 36.9M | 53.6M | 72.6M | 85.2M | 94.4M | 99.1M | |
Cash | 177.3M | 234.7M | 208.8M | 115.3M | 240.8M | 164.9M | |
Non Current Assets Total | 39.5M | 52.5M | 66.0M | 80.1M | 111.7M | 117.3M | |
Non Currrent Assets Other | 4.9M | 10.9M | 12.1M | 11.2M | 14.0M | 14.7M | |
Other Assets | 4.9M | 10.9M | 12.1M | 11.2M | 12.8M | 13.5M | |
Long Term Debt | 149.4M | 429.9M | 562.2M | 565.5M | 568.8M | 597.3M | |
Cash And Short Term Investments | 326.1M | 842.6M | 937.7M | 969.4M | 910.6M | 518.3M | |
Net Receivables | 88.1M | 117.9M | 110.6M | 112.2M | 77.1M | 63.0M | |
Common Stock Shares Outstanding | 97.2M | 108.9M | 103.4M | 104.7M | 106.4M | 96.1M | |
Short Term Investments | 148.8M | 607.9M | 728.9M | 854.1M | 669.8M | 353.5M | |
Liabilities And Stockholders Equity | 479.4M | 1.1B | 1.1B | 1.2B | 1.1B | 651.0M | |
Non Current Liabilities Total | 175.3M | 461.8M | 586.4M | 591.7M | 604.5M | 634.7M | |
Inventory | 23.7M | 27.4M | 24.4M | 29.4M | 38.2M | 23.2M | |
Other Current Assets | 1K | 11.5M | 807K | 6.7M | 8.5M | 4.5M | |
Other Stockholder Equity | 871.4M | 1.1B | 1.1B | 1.2B | 1.4B | 916.6M | |
Total Liab | 261.7M | 575.5M | 729.0M | 750.5M | 783.6M | 822.8M | |
Total Current Assets | 439.9M | 999.4M | 1.1B | 1.1B | 1.0B | 607.6M | |
Accumulated Other Comprehensive Income | (2.8M) | (3.8M) | (3.2M) | (2.4M) | (5.5M) | (5.2M) | |
Property Plant Equipment | 34.6M | 11.4M | 53.9M | 32.7M | 37.6M | 22.9M | |
Retained Earnings Total Equity | (650.9M) | (631.1M) | (685.9M) | (778.5M) | (700.6M) | (735.6M) | |
Current Deferred Revenue | 11.8M | 17.8M | 17.8M | 18.0M | 16.2M | 13.4M | |
Long Term Debt Total | 149.5M | 429.9M | 562.2M | 565.5M | 650.3M | 682.9M | |
Capital Surpluse | 871.4M | 1.1B | 1.1B | 1.2B | 1.4B | 1.0B | |
Non Current Liabilities Other | 182K | 31.9M | 166K | 148K | 18K | 17.1K | |
Net Invested Capital | 367.2M | 906.4M | 972.7M | 1.0B | 931.3M | 731.9M | |
Net Working Capital | 353.6M | 885.8M | 930.9M | 952.8M | 855.3M | 696.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.